News

Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...
Science-fiction once imagined doctors waving sleek “tricorders” over patients to read every vital sign in seconds. Today, ...
Here’s how aligning personal purpose with strategic vision can fuel innovation, unlock partnerships and drive meaningful ...
AliveCor is committed to innovating for patients, providers and the healthcare industry alike, said Sanjay Voleti, Chief Business Officer of AliveC ...
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews. KardiaAlert is a first ...
AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, today announced the launch of its most advanced personal ECG system, the groundbreaking AI-powered KardiaMobile ...
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews.
Apple defeats AliveCor bid to block US smartwatch imports in US appeal Apple has won a patent dispute against AliveCor regarding heart rate monitoring patents, preventing an import ban on Apple ...
Apple Watch: An Apple spokesperson said its teams have "worked tirelessly over many years to develop industry-leading health, wellness and safety features that meaningfully impact users' lives." ...
Apple has won a legal battle against health tech firm AliveCor, preventing a potential import ban on its Apple Watch models in the United States. The US Court of Appeals for the Federal Circuit ...
AliveCor had filed a case with ITC, claiming Apple had infringed on its EKG patents with the Apple Watch, and the ruling was in AliveCor's favor since ITC recommended an import ban on the sale of ...
Apple wins a legal battle against AliveCor as a U.S. court invalidates ECG patents, blocking a potential Apple Watch import ban amid an ongoing tech dispute.